2020
DOI: 10.1002/ajmg.a.61861
|View full text |Cite
|
Sign up to set email alerts
|

Prophylactic anticoagulation of individuals with Proteus syndrome and COVID‐19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…It is well known that patients with Proteus syndrome have an increased risk for deep vein thrombosis (DVT) and pulmonary embolism (PE); other researchers have argued that endothelial abnormalities, platelet dysfunction, and stasis associated with vascular malformations cause adverse effects on hemostasis [15]. However, prophylactic anticoagulation is not recommended due to the risk of life-threatening hemorrhage, especially in children, for minor trauma [16]. Only patients tested positive for DVT and PE on imaging should undergo acute anticoagulation [15].…”
Section: Discussionmentioning
confidence: 99%
“…It is well known that patients with Proteus syndrome have an increased risk for deep vein thrombosis (DVT) and pulmonary embolism (PE); other researchers have argued that endothelial abnormalities, platelet dysfunction, and stasis associated with vascular malformations cause adverse effects on hemostasis [15]. However, prophylactic anticoagulation is not recommended due to the risk of life-threatening hemorrhage, especially in children, for minor trauma [16]. Only patients tested positive for DVT and PE on imaging should undergo acute anticoagulation [15].…”
Section: Discussionmentioning
confidence: 99%